Kaufmann PA, Rimoldi OE, Gnecchi-Ruscone T, Luscher TF, Camici PG. Systemic nitric oxide synthase inhibition improves coronary flow reserve to adenosine in patients with significant stenoses. Am J Physiol Heart Circ Physiol 293: H2178-H2182, 2007. First published July 27, 2007; doi:10.1152/ajpheart.01292.2006.-We studied the impact of systemic infusion of the nitric oxide synthase (NOS) inhibitor N G -monomethyl-L-arginine (L-NMMA) on coronary flow reserve (CFR) in patients with coronary artery disease (CAD). We have previously demonstrated that CFR to adenosine was significantly increased after systemic infusion of L-NMMA in normal volunteers but not in recently transplanted denervated hearts. At baseline, myocardial blood flow (MBF; ml ⅐ min Ϫ1 ⅐ g Ϫ1 ) was measured at rest and during intravenous administration of adenosine (140 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ) in 10 controls (47 Ϯ 5 yr) and 10 CAD patients (58 Ϯ 8 yr; P Ͻ 0.01 vs. controls) using positron emission tomography and 15 O-labeled water. Both MBF measurements were repeated during intravenous infusion of 10 mg/kg L-NMMA. CFR was calculated as the ratio of MBF during adenosine to MBF at rest. CFR was significantly higher in healthy volunteers than in CAD patients and increased significantly after L-NMMA in controls (4.00 Ϯ 1.10 to 6.15 Ϯ 1.35; P Ͻ 0.0001) and in patients, both in territories subtended by stenotic coronary arteries (Ͼ70% luminal diameter; 2.06 Ϯ 1.13 to 3.21 Ϯ 1.07; P Ͻ 0.01) and in remote segments (3.20 Ϯ 1.23 to 3.92 Ϯ 1.62; P Ͻ 0.05). In conclusion, CFR can be significantly increased in CAD by a systemic infusion of L-NMMA. Similarly to our previous findings in normal volunteers, this suggests that adenosine-induced hyperemia in CAD patients is constrained by a mechanism that can be relieved by systemic NOS inhibition with L-NMMA. coronary circulation; autonomic nervous system; ischemic heart disease; cardiac imaging; positron emission tomography IT IS WELL ESTABLISHED THAT myocardial ischemia is a powerful stimulus for vasodilatation of coronary resistive vessels. The vasodilator response is reported to be near maximal for ischemic times of up to 15-20 s, while no further changes are observed for longer ischemic times (16).Experimental studies in animals have proven that intracoronary or intravenous infusion of adenosine achieves a degree of coronary vasodilatation comparable to that obtained after a period of ischemia of 15-20 s. In normal humans, intravenous infusion of 140 g/kg adenosine produces an increase in myocardial blood flow (MBF) approximately fourfold above the resting value with no further increase at higher adenosine doses (12,29).In a recent study in normal volunteers (15), we demonstrated that hyperemic MBF measured during the combined intravenous infusion of adenosine (140 g/kg) and the nitric oxide synthase (NOS) inhibitor N G -monomethyl-L-arginine (L-NMMA; 10 mg/ kg) was 53% higher than that during infusion of adenosine alone. This effect seems to necessitate an intact cardiac innervation, since no increase in MBF during ...